LAS VEGAS, July 17, 2014 /PRNewswire via COMTEX/ — BioAdaptives, Inc. (OTCBB:BDPT) is pleased to announce Dr. Charlie Timmerman, DVM has joined the Advisory Board for its equine products. Dr. Timmerman is a 1970 graduate of University of Georgia. He has practiced in Aiken, South Carolina since graduating and opened the Aiken Veterinary clinic in 1972.
BioAdaptives, under the direct supervision of Mr. Barry Epling, Chairman and CEO, has been testing two equine products in Aiken, South Carolina, Las Vegas, Nevada, Australia, and Singapore. Mr. Epling stated, “We knew the products increased stem cells but what exactly does that increase mean to the consumer, whether it be a human or animal? Dr. Timmerman’s efforts have helped us to determine some of the benefits to horses.”
Dr. Timmerman stated, “I started these trials and subjective observations on horses in Aiken on the two BioAdaptives natural products for equine consumption on 24 polo ponies from April 2014 to June 2014. The trainers and riders have been impressed with the fact that all horses have improved their physical fitness and drive. They also found that these polo ponies are more manageable during matches, even when playing or practicing 4-5 days a week in hot and humid conditions.”
“A leading thoroughbred trainer commented that he had been around horses since seven and had never seen anything like the results of these two natural products. He said that he could not believe what he was seeing, in particular on a horse that was having extreme difficulties in bending his front leg. Within four weeks on the product, this horse could bend the same leg to full extension and touch his belly,” Dr. Timmerman added.
The three month trial and observations on these two natural equine products found that horses on these products have considerable growth and strengthening of hooves; better appearance of skin and luster; with increased endurance and faster recovery after a match and transportation. The products are also observed to assist non-sweating horses to naturally sweat. “Additional studies and trials for both human and animal consumption are currently continuing in the United States and Overseas. We look forward to translating these trial successes into market place successes in the near future,” said Mr. Barry Epling.
About BioAdaptives, Inc.
BioAdaptives, Inc. is a fully-reporting public company trading on the OTC Bulletin Board under the symbol BDPT. The company is engaged in research and development in science-based nutraceutical products for both human and animal consumption. The company’s focus, in conjunction with Ferris Holding, Inc., is to source high quality, unique raw material worldwide and develop science-based products to improve health and wellness for both humans and animals. It has also developed a proprietary method that is a non-intrusive bioelectromagnetic device for improving food, beverages, and wellness.
SAFE HARBOR ACT
Forward-Looking Statements: This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of BioAdaptives, Inc its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond BioAdaptives, Inc’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in BioAdaptives, Inc’s filings with the Securities and Exchange Commission.